Craft

Asarina Pharma

Total Funding

$24.7 M

Asarina Pharma Summary

Company Summary

Overview
Asarina Pharma is a company that develops treatments for premenstrual dysphoric syndrome and menstrual-related diseases. It provides Sepranolone, a non-hormonally active compound that inhibits the disease provoking effect of the progesterone metabolite, allopregnanolone, in women suffering from PMDD.
Type
Private
Status
Active
Founded
2006
HQ
Solna, SE | view all locations
Website
https://asarinapharma.com/
Cybersecurity rating
Sectors

Key People

  • Paul de Potocki

    Paul de Potocki, Chairman of the Board

    • Peter Nordkild

      Peter Nordkild, Chief Executive Officer

      • Marianne Kock

        Marianne Kock, Director of the Board

        • Miroslav Reljanovic

          Miroslav Reljanovic, Director of the Board

          LocationsView all

          2 locations detected

          • Solna, Stockholms län HQ

            Sweden

            Fogdevreten 2

          • København

            Denmark

            Ole Maaløes Vej 3

          Footer menu